Last reviewed · How we verify
Apolipoprotein E genotyping
At a glance
| Generic name | Apolipoprotein E genotyping |
|---|---|
| Sponsor | Assistance Publique Hopitaux De Marseille |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Digital Technology for Active and Healthy Ageing in Taiwan (NA)
- GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) Genotype
- Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study (NA)
- A Prospective, Monocentric Clinical Study for the Validation of in Vitro Diagnostic Tests Developed by Firalis
- Cardiorespiratory Fitness, Apolipoprotein E Genotype, and Cognitive Functions: A Prospective Study
- Apolipoprotein E (APOE) Genotype Effects on Triglycerides and Blood Flow in the Human Brain (NA)
- Polymorphism of ApoE in Alzheimer's Disease: Genetic Study in Castile and Leon (Spain) (NA)
- Spatial and Ocular Trajectories for the Early Diagnosis of Alzheimer's Disease. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Apolipoprotein E genotyping CI brief — competitive landscape report
- Apolipoprotein E genotyping updates RSS · CI watch RSS
- Assistance Publique Hopitaux De Marseille portfolio CI